《中国脑卒中防治报告2020》概要

Brief report on stroke prevention and treatment in China,2020

卒中是我国成人致死、致残的首要原因,随着人口老龄化和城市化进程加速,卒中危险因素流行趋势明显,我国卒中疾病负担有增长的态势。卒中作为一种可防可控的疾病,早期筛查、干预效果显著。近几年的“脑卒中高危人群筛查和干预项目”取得初步成效,全球疾病负担研究(GBD)数据显示,我国卒中发病率由2005年222/10万下降至2019年201/10万,但患病率仍处于上升阶段。2019年“脑卒中高危人群筛查和干预项目”数据显示,我国40岁及以上人群的卒中人口标化患病率由2012年的1.89%上升至2019年的2.58%,至2019年我国40岁及以上人群现患和曾患卒中人数约为1704万。因此,为遏制卒中疾病负担增长态势,我国卒中防控力度亟待进一步加强。该概要从卒中的流行病学、诊治进展、防治体系建设以及高危人群筛查和干预项目四个方面系统总结了2019年我国的卒中防治工作,并对下一步的工作作出规划和展望。

Stroke is the leading cause of mortality and morbidity for adults in China.With the rapid population aging and urbanization,risk factors for stroke prevail.Stroke is preventable and controllable,and early screening and intervention are effective.The China National Stroke Screening and Prevention Project(CNSSPP)for high-risk stroke patients have achieved initial results.According to the data of Global Burden of Disease Study(GBD),the incidence of stroke in China has decreased from 222/100000 in 2005 to 201/100000 in 2019.However,the prevalence of stroke is still on the rise.The CNSSPP shows the standardized prevalence of stroke increased from 1.89%in 2012 to 2.58%in 2019 among adults aged≥40 years old.It is estimated that the number of stroke patients aged≥40 years old in China is about 17.04 million by 2019.Therefore,stroke prevention and control need to be further strengthened to curb the trend of growing burden of stroke.In this paper,the stroke prevention and treatment work in China in 2019 have been systematically summarized from four aspects:epidemiology of stroke,progress in stroke management,stroke prevention and treatment systems and CNSSPP.The paper also makes plans and prospects of stroke for the next step.